First Report of 3-Year Clinical Outcome After Treatment With Novel Resolute Onyx Stents in the Randomized BIONYX Trial.

Background: At 1 year, the international randomized BIONYX trial (ClinicalTrials.gov:NCT02508714) established non-inferiority regarding safety and efficacy of the novel Resolute Onyx zotarolimus-eluting stent (RO-ZES) vs. the Orsiro sirolimus-eluting stent (O-SES).

Use of the float-moor-crush approach for subtotal mid-segment collapse of a protruding aorto-ostial vein graft stent: a case report.

Introduction: Aorto-ostial stenting remains one of the most demanding and risky types of angioplasty to perform. We report a case outlining a creative solution for the reengagement of a protruding aorto-ostial stent.

Case Presentation: A 69-year-old Caucasian man was admitted to our hospital's coronary care unit with progressive unstable angina five years following coronary artery bypass grafting and three years after percutaneous coronary intervention of the graft.

Electromechanical mapping of the left ventricle: possible tool for online decision making in the catheterization laboratory.

Clinical decision making in intervention cardiology often depends on information about the presence of myocardial viability and the extent of ischemia. Especially in the case of an occluded collaterally filled coronary branch, online decision making in selected patients may accelerate and improve patient care. The electromechanical NOGA mapping system offers the opportunity for online viability assessment.